Amgen (AMGN) Return on Equity [ROE] (2009 - 2026)
Amgen (AMGN) reported Return on Equity [ROE] of 83.75% for Q2 2026, down 13.34 percentage points from 97.09% a year earlier and down 3.65 percentage points from the prior quarter.
Powered by 
Analysis
Amgen (AMGN) Return on Equity [ROE] (2009 - 2026) Analysis & Trends
For FY2025, Amgen posted Return on Equity [ROE] of 106.10%, up 38.55 percentage points from FY2024.
- Return on Equity [ROE] has a five-year change of +29.97 percentage points (FY2020 to FY2025).
- By year, Return on Equity [ROE] came in at 67.55% in FY2024 (-68.24 pp), 135.79% in FY2023 (+9.32 pp), 126.47% in FY2022 (+53.31 pp) and 73.16% in FY2021 (-2.97 pp).
- Five-year quarterly Return on Equity [ROE] spans a low of 57.18% in Q2 2024 and a high of 394.36% in Q2 2022.
- Year over year, Return on Equity [ROE] gained in four of the last eight quarters, with an average year-over-year change of +1.51 percentage points.
- The high point for year-over-year Return on Equity [ROE] in five years was Q2 2022 (a gain of 329.00 percentage points); the low point was Q2 2023 (a drop of 262.79 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at 87.40% (Q1 2026), 84.38% (Q4 2025) and 82.18% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,248.18 Bn | 1,221.79 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 676.30 Bn | 596.16 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 517.93 Bn | 485.94 Bn | 13.12 Bn | - |
| 4 | Merck | 364.09 Bn | 327.03 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 315.96 Bn | 289.20 Bn | - | - |
| 6 | Astrazeneca | 292.99 Bn | 266.88 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 250.53 Bn | 202.18 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 209.76 Bn | 184.86 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.38 Bn | 114.74 Bn | 12.56 Bn | 4.66% |
| 10 | Vertex Pharmaceuticals | 138.91 Bn | 110.90 Bn | 2.91 Bn | 19.32% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 72.13% |
| Jun 30, 2026 | 83.75% |
| Mar 31, 2026 | 87.40% |
| Dec 31, 2025 | 84.38% |
| Sep 30, 2025 | 82.18% |
| Jun 30, 2025 | 97.09% |
| Mar 31, 2025 | 98.20% |
| Dec 31, 2024 | 61.03% |
| Sep 30, 2024 | 62.89% |
| Jun 30, 2024 | 57.18% |
| Mar 31, 2024 | 66.87% |
| Dec 31, 2023 | 96.73% |
| Sep 30, 2023 | 104.81% |
| Jun 30, 2023 | 131.57% |
| Mar 31, 2023 | 175.76% |
| Dec 31, 2022 | 179.16% |
| Sep 30, 2022 | 225.13% |
| Jun 30, 2022 | 394.36% |
| Mar 31, 2022 | 150.29% |
| Dec 31, 2021 | 79.01% |
API Access
Amgen Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=AMGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "AMGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=AMGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();